Key result
High glucose-to-platelet ratio is linked to ~60% higher 30-day mortality in critically ill AMI patients.
Why the study?
The prognostic value of the glucose-to-platelet ratio in ICU patients with acute myocardial infarction remains unclear.
Does an elevated glucose-to-platelet ratio (GPR) predict increased short- and long-term all-cause mortality in critically ill patients with acute myocardial infarction?
Cohort (n=4,676)
No
Does an elevated glucose-to-platelet ratio (GPR) predict increased short- and long-term all-cause mortality in critically ill patients with acute myocardial infarction?
Higher glucose-to-platelet ratio (GPR) is independently associated with increased short- and long-term all-cause mortality in critically ill patients with AMI, serving as a potential early prognostic marker.
Answers are grounded in this paper and cite their sources.
May inform early risk stratification in critically ill AMI; leaves open prospective validation before any practice change.
Acute myocardial infarction (AMI) in critically ill patients is associated with high mortality. The glucose-to-platelet ratio (GPR), derived from routine early glucose and platelet measurements, may provide additional prognostic information, but its value in ICU patients with AMI remains unclear. This retrospective cohort study included 4,676 adult ICU patients with AMI from the MIMIC-IV version 3.1 database. GPR was calculated as the mean glucose concentration during the first 24 h after ICU admission divided by the first platelet count recorded within the same period. Outcomes were 30-day and 360-day all-cause mortality from ICU admission. Associations were assessed using multivariable Cox proportional hazards models, restricted cubic splines, and exploratory internally validated prediction models. Among 4,676 patients, the 30-day and 360-day mortality rates were 19.6% and 29.1%, respectively. In the fully adjusted model, each 1-unit increase in GPR was associated with higher 30-day mortality (HR, 1.10; 95% CI, 1.05–1.15) and 360-day mortality (HR, 1.12; 95% CI, 1.07–1.16; both P < 0.001). Compared with the lowest tertile, the highest GPR tertile was associated with increased 30-day mortality (HR, 1.60; 95% CI, 1.35–1.90) and 360-day mortality (HR, 1.29; 95% CI, 1.12–1.47; both P < 0.001). Spline analyses suggested nonlinearity only for 30-day mortality. In exploratory internal validation, ridge regression incorporating GPR achieved an area under the receiver operating characteristic curve of 0.816. Higher GPR was independently associated with increased short- and long-term all-cause mortality in critically ill patients with AMI. GPR may complement conventional variables for early ICU risk stratification.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Acute myocardial infarction in critically ill patients (n=4,676). Glucose-to-platelet ratio (highest tertile) vs. Lowest glucose-to-platelet ratio tertile was evaluated on 30-day all-cause mortality (HR 1.60, 95% CI 1.35-1.90, p=<0.001). The highest glucose-to-platelet ratio tertile was associated with a significantly increased risk of 30-day all-cause mortality (HR 1.60) compared to the lowest tertile in critically ill AMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: